Takahiro Kimura

Featured in: Favicon

nature.com Favicon

wiley.com (+1) Favicon

tandfonline.com Favicon

europeanurology.com Favicon

archivesofpathology.org Favicon

pubs.acs.org Favicon

Articles

Tumor burden and heterogenous treatment effect of apalutamide in metastatic castration‐sensitive prostate cancer

1 month ago | acsjournals.onlinelibrary.wiley.com | Wataru Fukuokaya |Keiichiro Mori |Takafumi Yanagisawa |Fumihiko Urabe |Pawel Rajwa |Alberto Briganti | +4 more
Salvage therapies for biochemical recurrence after definitive local treatment: a systematic review, meta-analysis, and network meta-analysis - Prostate Cancer and Prostatic Diseases

Sep 12, 2024 | nature.com | Akihiro Matsukawa |Takafumi Yanagisawa |Marcin Miszczyk |Ichiro Tsuboi |Ekaterina Laukhtina |Juan Rivas | +4 more

AbstractRecent advancements in the management of biochemical recurrence (BCR) following local treatment for prostate cancer (PCa), including the use of androgen receptor signaling inhibitors (ARSIs), have broadened the spectrum of therapeutic options. We aimed to compare salvage therapies in patients with BCR after definitive local treatment for clinically non-metastatic PCa with curative intent.
Cardiovascular events among men with prostate cancer treated with androgen receptor signaling inhibitors: a systematic review, meta-analysis, and network meta-analysis | Prostate Cancer and Prostatic Diseases

Sep 4, 2024 | nature.com | Akihiro Matsukawa |Takafumi Yanagisawa |Ekaterina Laukhtina |Takahiro Kimura |Pawel Rajwa

AbstractAndrogen-receptor pathway inhibitors (ARPIs) have dramatically changed the management of advanced/metastatic prostate cancer (PCa). However, their cardiovascular toxicity remains to be clarified.

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →